Artificial intelligence to investigate metabolomics data for precision medicine

Antony Shenouda1, Sahana Senthilkumar1, Youssef Mourad1

  • 1Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, 112 Paterson Street, New Brunswick, NJ, 08901, USA.

Summary

Artificial intelligence (AI) and machine learning (ML) significantly advance metabolomics for disease insights. These AI/ML methods aid biomarker discovery and disease prediction, crucial for precision medicine.